HealthEquity, Inc. $HQY Stock Bought by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al boosted its position in HealthEquity, Inc. (NASDAQ:HQY) by 53.8% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 44,600 shares of the company’s stock after purchasing an additional 15,600 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in HealthEquity were worth $3,945,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Signaturefd LLC raised its stake in shares of HealthEquity by 11.7% during the third quarter. Signaturefd LLC now owns 1,359 shares of the company’s stock worth $120,000 after acquiring an additional 142 shares in the last quarter. GAMMA Investing LLC boosted its position in HealthEquity by 12.0% during the third quarter. GAMMA Investing LLC now owns 1,479 shares of the company’s stock valued at $131,000 after buying an additional 158 shares during the period. Cim Investment Management Inc. boosted its position in HealthEquity by 5.0% during the second quarter. Cim Investment Management Inc. now owns 4,007 shares of the company’s stock valued at $362,000 after buying an additional 191 shares during the period. State of Michigan Retirement System grew its stake in shares of HealthEquity by 1.0% during the first quarter. State of Michigan Retirement System now owns 20,522 shares of the company’s stock valued at $1,715,000 after buying an additional 200 shares during the last quarter. Finally, Leonteq Securities AG grew its stake in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after buying an additional 235 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

Insider Buying and Selling at HealthEquity

In other news, Director Adrian Dillon sold 7,632 shares of HealthEquity stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the transaction, the director owned 62,395 shares of the company’s stock, valued at $6,527,140.95. The trade was a 10.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is owned by insiders.

HealthEquity Stock Performance

NASDAQ:HQY opened at $102.47 on Monday. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $107.62. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. The company’s 50-day simple moving average is $95.37 and its 200 day simple moving average is $89.04. The firm has a market capitalization of $8.48 billion, a P/E ratio of 36.99, a PEG ratio of 1.62 and a beta of 0.22.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The business had revenue of $350.73 million during the quarter, compared to analysts’ expectations of $349.22 million. The business’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, analysts forecast that HealthEquity, Inc. will post 3.94 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently commented on HQY. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, October 10th. Raymond James Financial restated a “strong-buy” rating on shares of HealthEquity in a report on Thursday, September 3rd. Barclays raised their price target on HealthEquity from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Friday, September 18th. BTIG Research reaffirmed a “buy” rating and issued a $115.00 target price on shares of HealthEquity in a research note on Friday, August 28th. Finally, BMO Capital Markets boosted their price target on HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a report on Wednesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and a consensus price target of $113.53.

About HealthEquity

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.